Permanently Discontinued

MYLAN-BUPRENORPHINE/NALOXONE

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MYLAN-BUPRENORPHINE/NALOXONE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MYLAN-BUPRENORPHINE/NALOXONE 8MG 2MG has been permanently discontinued (last updated September 18, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MYLAN-BUPRENORPHINE/NALOXONE not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength8MG 2MG

Last updated2019-09-18

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02408104

Strength

8MG 2MG

Dosage Form

TABLET

Route

SUBLINGUAL

Active Ingredient

BUPRENORPHINE NALOXONE

Tier

Unrated

Last Updated

2019-09-18

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from MYLAN PHARMACEUTICALS ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZITHROMYCIN FOR INJECTION, USP

500MG · DIN 02385473

333MG · DIN 02293269

40MG · DIN 02257963

10MG · DIN 02257955

DIN 02388138

DIN 02388146